Member access

4-Traders Homepage  >  Shares  >  Deutsche Boerse AG  >  DAIICHI SANKYO COMPANY, LIMITED    D4S   JP3475350009

SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisionsForum 
Sector
Healthcare
Biotechnology / Pharmaceuticals
 Biotechnology / Pharmaceuticals
  Pharmaceuticals - Diversified
Logo
Logo DAIICHI SANKYO COMPANY, LI
Surperformance© rating of DAIICHI SANKYO COMPANY, LI
Overall rating In sector In country
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
PER
Potential
Yield
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
More Ratings
Sector Pharmaceuticals - Diversified
CountryTrading RatingInvestor Rating
JOHNSON & JOHNSONUSA
ROCHE HOLDING LTD.Switzerland
PFIZER INC.USA
NOVARTIS AGSwitzerland
SANOFIFrance
MERCK & CO., INC.USA
GLAXOSMITHKLINE PLCUnited Kingdom
BAYER AGGermany
BRISTOL MYERS SQUIBB CO.USA
NOVO NORDISK A/SDenmark
ELI LILLY & CO.USA
ABBOTT LABORATORIESUSA
TEVA PHARMACEUTICAL INDUSTRIES LIMITEDISRAEL
SHIRE PLCUnited Kingdom
ALEXION PHARMACEUTICALS, INC.USA
ACTAVIS INCUSA
MYLAN INC.USA
DAIICHI SANKYO COMPANY, LIMITEDJapan
CHUGAI PHARMACEUTICAL CO., LTD.Japan
UCBBelgium
BIOMARIN PHARMACEUTICAL INC.USA
TASLY PHARMACEUTICAL GROUP CO LTDCHINA
TAISHO PHARMACEUTICAL HOLDINGS CO LTDJapan
WARNER CHILCOTT PLCUSA
HISAMITSU PHARMACEUTICAL CO., INC.Japan
Sector Pharmaceuticals - Diversified
Data source :
© 2013 Thomson Reuters		 Ratings :
© 2013 Surperformance
Advertisement
Dynamic quotes  
ON
| OFF
My Watchlist|My Portfolio
4-traders.com :
About :
Stay Connected :
Copyright © 2013 Surperformance. All rights reserved.